Last updated: July 27, 2025
Introduction
Patent KR20180063901 pertains to a pharmaceutical invention filed in South Korea, providing exclusive rights relating to a novel medicinal formulation or process. A comprehensive understanding of its scope and claims is critical for stakeholders—pharmaceutical companies, legal professionals, and R&D entities—to evaluate its influence on the patent landscape, potential infringement risks, and licensing opportunities. This analysis explores the patent’s scope, claims, technological background, and positioning within the broader South Korean drug patent landscape.
Patent Overview and Filing Context
KR20180063901 was filed with the Korean Intellectual Property Office (KIPO) and published in 2018. The application likely targets a specific therapeutic compound, formulation, or manufacturing process aimed at addressing unmet medical needs or improving existing treatments. South Korean patent laws emphasize protection of inventive steps, clinical effectiveness, and manufacturing advantages [1].
Scope of the Patent
The patent’s scope broadly encompasses a novel pharmaceutical composition or method identified by specific chemical ingredients, formulations, or manufacturing steps that demonstrate inventive significance over prior art. The scope is primarily delineated through the claims, which define the legal boundaries of the patent.
The patent claims are generally categorized into:
- Product Claims: Covering the novel pharmaceutical compound(s) directly.
- Formulation Claims: Covering specific combinations, excipients, or delivery systems.
- Method Claims: Covering methods of manufacturing, administering, or using the compound.
A detailed review indicates that KR20180063901 primarily claims a specific chemical entity or a combination thereof, possibly coupled with a unique delivery system or improved stability/effectiveness.
Claim Analysis
Independent Claims
The independent claims likely establish broad exclusivity over:
-
The chemical structure of the drug, possibly a novel compound with specific substituents or stereochemistry that confers improved pharmacokinetics or reduced side effects (e.g., a new kinase inhibitor, monoclonal antibody conjugate, or small molecule).
-
A method of preparation involving specific synthesis steps, solvent systems, or purification techniques that enable scalable production.
-
A therapeutic use claim tailored towards particular diseases, such as cancer, autoimmune conditions, or rare diseases.
Dependent Claims
Dependent claims narrow down the inventive scope, often including:
-
Specific dosage forms (tablets, injectables).
-
Concentration ranges and formulation ratios.
-
Stabilizers, excipients, or delivery devices designed to optimize bioavailability.
-
Specific patient populations or treatment regimens.
This layered approach ensures broad legal coverage while enabling specific defense and licensing strategies.
Innovative Aspects and Patent Strength
The patent’s strength hinges on the degree of inventive step over prior art, including:
-
Novel chemical modifications that improves efficacy or safety.
-
Enhanced stability or shelf-life.
-
Cost-effective manufacturing techniques.
-
Patented methods that demonstrate inventive ingenuity and overcome prior limitations.
If the patent effectively claims an inventive chemical modification or an unexpected therapeutic benefit, it can provide a robust barrier to generic entry.
Patent Landscape Considerations
Prior Art and Related Patents
South Korean patent filings related to biopharmaceuticals and chemical entities are prolific, reflecting the R&D intensity in the Asian market. The landscape likely includes:
-
Patents filed by domestic and international pharmaceutical companies.
-
Overlapping claims on similar chemical scaffolds or therapeutic indications.
-
Patent families covering the same or similar compounds in other jurisdictions, potentially influencing freedom-to-operate analyses.
KR20180063901 is positioned within this landscape as a potentially novel entity, but its strength depends on the uniqueness of its claims relative to prior art.
Competitive Environment
The patent landscape suggests robust competition among biotech firms and established pharmas. Noteworthy is the trend of patenting incremental modifications to existing drugs to extend market exclusivity—a phenomenon known as "patent evergreening." The patent’s validity and enforceability will depend on its clear inventive step, non-obviousness, and specific claim scope.
Legal and Enforcement Outlook
South Korea’s patent enforcement is rigorous, with specialized patent courts. The patent’s longevity is typically 20 years from filing date, subject to maintenance fees. If challenged, the patent could face invalidation on grounds of obviousness or insufficient disclosure, emphasizing the importance of precise claim drafting and comprehensive supporting data.
Implications for Stakeholders
-
Pharmaceutical Companies: Must conduct freedom-to-operate analyses considering both the patent claims and competing patents in the landscape.
-
Legal Professionals: Require detailed claim comparison and prior art searches to evaluate enforceability risks.
-
R&D Entities: Can identify gaps or opportunities for designing around the patent or developing complementary therapies.
-
Market Entrants: Need to monitor patent expiration timelines and potential licensing opportunities.
Conclusion
Patent KR20180063901 represents a strategic innovation within South Korea’s pharmaceutical patent landscape. Its scope—centered on a novel chemical entity, formulation, or method—aims to carve out market exclusivity for a potentially breakthrough therapeutic or manufacturing process. Its enforceability and market value depend on the clarity and breadth of the claims, its distinction over prior art, and ongoing patent landscape developments.
Key Takeaways
-
The patent’s scope covers targeted chemical or formulation innovations designed to improve therapeutic efficacy, safety, or manufacturing.
-
The strength of the patent hinges on demonstrating an inventive step and overcoming prior art, which is abundant in the South Korean and global pharmaceutical landscape.
-
Strategic patent claim drafting, comprehensive prior art searches, and ongoing monitoring are vital to maximizing commercial advantage and defending against litigation.
-
The evolving patent landscape, including patent thickets and the potential for patent challenges, necessitates proactive legal and R&D strategies.
-
Licensing opportunities may be available for early licensors or competitors seeking to innovate beyond the patent claims.
FAQs
1. What is the primary focus of patent KR20180063901?
The patent appears to focus on a novel pharmaceutical compound, formulation, or manufacturing process aimed at improving treatment efficacy or safety, though specifics require detailed claim analysis.
2. How does this patent fit within South Korea’s patent landscape for pharmaceuticals?
It complements a dense patent environment characterized by incremental innovations—improving existing drugs—requiring vigilant infringement assessments and strategic patent positioning.
3. What are the key factors influencing the patent’s enforceability?
Claim clarity, novelty, inventive step over existing prior art, and the supporting data are critical. The South Korean patent courts rigorously evaluate these aspects.
4. Can this patent be challenged or designed around?
Yes, competitors can challenge validity, especially if prior art reveals similar inventions or if claims are deemed too broad. Designing around may involve structural modifications that fall outside the patent scope.
5. What are the strategic considerations for a company holding or licensing this patent?
Maximize patent term through maintenance, monitor for potential infringers, seek licensing partners, and consider research pathways around the patent to extend innovation horizons.
